0001574251-19-000001.txt : 20190524 0001574251-19-000001.hdr.sgml : 20190524 20190523175215 ACCESSION NUMBER: 0001574251-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190524 DATE AS OF CHANGE: 20190523 EFFECTIVENESS DATE: 20190524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mati Therapeutics Inc. CENTRAL INDEX KEY: 0001574251 IRS NUMBER: 462000931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-340303 FILM NUMBER: 19851373 BUSINESS ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 329-6360 MAIL ADDRESS: STREET 1: 4317 DUNNING LANE CITY: AUSTIN STATE: TX ZIP: 78746 D 1 primary_doc.xml X0708 D LIVE 0001574251 Mati Therapeutics Inc. 4317 Dunning Lane Austin TX TEXAS 78746 512-329-6360 DELAWARE None None Corporation true Robert Lee Butchofsky II 4317 Dunning Lane Austin TX TEXAS 78746 Executive Officer Director Cameron Nelson 3505 West 36th Avenue Vancouver A1 BRITISH COLUMBIA, CANADA V6N 2S1 Executive Officer Christopher Muller 3 Verona Lane Foothill Ranch CA CALIFORNIA 92610 Executive Officer Director Deepank Utkhede 18623-68th Avenue Surrey A1 BRITISH COLUMBIA, CANADA V3S 9C6 Executive Officer Director Biotechnology Decline to Disclose 06b false 2019-05-11 false true false 0 1500000 165030 1334970 false 2 0 0 0 false Mati Therapeutics Inc. Robert Lee Butchofsky II Robert Lee Butchofsky II Chief Executive Officer 2019-05-23